NeurAxon
closedNeurAxon discovers and develops pain therapeutics targeted on neuronal nitric oxide synthase.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD5—7m (Dealroom.co estimates May 2012.)
Toronto Ontario (HQ)
Authorizing premium user...